11. COMMON STOCK As of June 30, 2026, the Company had authorized 500,000,000 shares of common stock. As of June 30, 2026, the Company had reserved 31,608,681 shares for the exercise of outstanding stock options and the number of shares remaining available for grant under the 2026 Equity Incentive Plan (see Note 12).
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2026 |
|
|
2025 |
|
Series A convertible preferred stock outstanding |
|
|
— |
|
|
|
26,398,943 |
|
Series B convertible preferred stock outstanding |
|
|
— |
|
|
|
20,745,628 |
|
Series C convertible preferred stock outstanding |
|
|
— |
|
|
|
22,188,673 |
|
Stock options outstanding |
|
|
24,376,545 |
|
|
|
20,422,301 |
|
Shares reserved for future issuance under the 2019 Plan |
|
|
— |
|
|
|
3,404,855 |
|
Shares reserved for exercise of outstanding Warrant |
|
|
— |
|
|
|
98,749 |
|
Shares reserved for future issuance under the 2026 Plan |
|
|
7,232,136 |
|
|
|
— |
|
Total shares of common stock reserved for issuance |
|
|
31,608,681 |
|
|
|
93,259,149 |
|
|